| Pfizer AG - Somavert 20 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 57144 | | 03 | | Somavert 20 mg | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | H01AX01 | | Pegvisomant | | 11.10.2005 | | |
|
| Composition |
| Praeparatio cryodesiccata: pegvisomantum 20 mg, glycinum, mannitolum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus pro vitro corresp. natrium 0.4 mg.
Solvens: aqua ad iniectabile 1 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisat et solvant | | | | | | | | Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
| | | | Agents auxilliaires |
|---|
| Disodium Phosphate | | Glycine | | Mannitol | | Sodium Dihydrogenophosphate Monohydrate |
| |
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
|
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
|
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
|
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
|
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
|
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Pegvisomant | 20 mg |
|
|
|
